​
Login / Signup

Wenwen Xu

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3
20252016

Top Topics

20252016
Pseudomonas Aeruginosa
20252016
Multidrug Resistant
20252016
Molecularly Imprinted
20252016
Chemotherapy Induced

Top Venues

Pharmaceutics
Journal of analytical methods in chemistry
This page only lists publications with an associated author ORCID identifier.
Publications
  • Wenwen Xu, Yumeng Xiao, Liang Zheng, Mingyu Xu, Xuehua Jiang, Ling Wang
    Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein. Pharmaceutics 15 (12) (2023)
  • Wenwen Xu, Yumeng Xiao, Liang Zheng, Mingyu Xu, Xuehua Jiang, Ling Wang
    Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein. Pharmaceutics 15 (12) (2023)
  • Wei Xiong, Ling Wang, Haiyan Zhang, Xiaoqiu Tao, Xuehua Jiang, Zejuan Liu, Jiajia Zhao, Wenwen Xu
    Quantitation of Apremilast in Beagle Dogs Plasma by UPLC-MS-MS and Its Application to Pharmacokinetic Studies. Journal of analytical methods in chemistry 2021 (2021)